PubRank

P H Gilligan

Author PubWeight™ 79.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987 7.82
2 Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988 5.71
3 Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985 4.26
4 Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol 1996 3.20
5 Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1985 3.09
6 Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol 1987 2.59
7 Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995 2.31
8 Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 1992 2.25
9 Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1993 2.22
10 Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997 2.09
11 Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 1987 1.80
12 Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis 1983 1.78
13 Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol 1984 1.70
14 Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol 1981 1.56
15 Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis 1990 1.54
16 Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001 1.52
17 Survival of human immunodeficiency virus in blood culture systems. Arch Pathol Lab Med 1988 1.51
18 Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol 1996 1.49
19 Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis 1988 1.42
20 Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J 1994 1.34
21 Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol 1993 1.28
22 Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics 1985 1.24
23 Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur J Clin Microbiol 1987 1.21
24 Capnocytophaga ochracea septicemia. J Clin Microbiol 1981 1.18
25 Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli. Infect Immun 1979 1.18
26 Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatr 1985 1.16
27 Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol 1995 1.14
28 Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 2000 1.12
29 Evaluation of the campyslide agglutination test for confirmatory identification of selected Campylobacter species. J Clin Microbiol 1988 1.09
30 Absorption of oral vancomycin - possible associated toxicity. Int J Pediatr Nephrol 1983 1.08
31 The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997 1.04
32 Clostridium difficile in patients with cystic fibrosis. Am J Dis Child 1985 1.03
33 Clostridium difficile peritonitis in a neonate. A case report. Arch Pathol Lab Med 1984 1.01
34 Pertussis is rare in human immunodeficiency virus disease. Am Rev Respir Dis 1993 1.00
35 Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol 1994 0.97
36 In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother 1990 0.95
37 Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child 1983 0.93
38 Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J Clin Microbiol 1995 0.90
39 Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Infect Immun 1983 0.90
40 Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr Pulmonol 1997 0.89
41 Evaluation of the latex agglutination test for detection of Clostridium difficile. Arch Pathol Lab Med 1992 0.89
42 Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis 1993 0.86
43 Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. J Pediatr 1986 0.81
44 Antigenuria after Haemophilus influenzae type b polysaccharide vaccination. J Pediatr 1986 0.81
45 Diarrheal disease in the hospitalized patient. Infect Control 1986 0.79
46 Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Eur J Clin Microbiol 1987 0.77
47 In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center. Antimicrob Agents Chemother 1991 0.77
48 Effect of imipenem-cilastatin therapy on fecal flora. Antimicrob Agents Chemother 1986 0.77
49 In vivo and in vitro studies of Clostridium difficile-induced disease in hamsters fed an atherogenic, high-fat diet. Lab Anim Sci 1995 0.76
50 Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test. Appl Environ Microbiol 1983 0.75
51 Yersinia enterocolitica meningitis and osteomyelitis: a case report. Diagn Microbiol Infect Dis 1987 0.75
52 Effect of lindane on nitroreductase and dechlorinase enzyme activity in the gastrointestinal tract. Toxicol Lett 1990 0.75